# The dawn of biophysical representations in computational immunology

**Authors:** Eric Wilson, Akshansh Kaushik, Soumya Dutta, Abhishek Singharoy, Mohd Ahsan

PMC · DOI: 10.1017/qrd.2025.7 · 2025-05-28

## TL;DR

This paper argues that using biophysical models in immunology can better connect genetic data to biological outcomes and improve the speed and interpretability of computational methods.

## Contribution

The novelty lies in advocating for biophysical representations to enhance genotype-phenotype mapping with interpretability and efficiency.

## Key findings

- Biophysical representations reduce the complexity of genotype-phenotype mapping problems.
- These representations provide interpretable insights across multiple biological scales.
- They can accelerate computational algorithms in immunology.

## Abstract

Computational immunology has been the breeding ground of some of the best bioinformatics work of the day. By melding diverse data types, these approaches have been successful in associating genotypes with phenotypes. However, the representations (or spaces) in which these associations are mapped have primarily been constructed from some omics-oriented sequence data typically derived from high-throughput experiments. In this perspective, we highlight the importance of biophysical representations for performing the genotype–phenotype map. We contend that using biophysical representations reduces the dimensionality of a search problem, dramatically expedites the algorithm, and more importantly, offers physical interpretability to the classes of clustered sequences across different layers of complexity – molecular, cellular, or macro-level. Such biophysical interpretations offer a firm basis for the future of bioengineering and cell-based therapies.

## Full-text entities

- **Genes:** TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** HIV disease (MESH:D015658), cancer (MESH:D009369), influenza infections (MESH:D007251), malaria (MESH:D008288), J&amp;J's COVID (MESH:C563874), ovarian cancer tumor (MESH:D010051), COVID-19 (MESH:D000086382), autoimmune diseases (MESH:D001327)
- **Chemicals:** glycan (MESH:D011134), adalimumab (MESH:D000068879), polymer (MESH:D011108), CR3022 (MESH:C000717587)
- **Species:** Homo sapiens (human, species) [taxon 9606], Gammacoronavirus (genus) [taxon 694013], Gallus gallus (bantam, species) [taxon 9031], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], H1N1 subtype (serotype) [taxon 114727]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12304778/full.md

---
Source: https://tomesphere.com/paper/PMC12304778